Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-08

Clinical Trial Update: The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France.

View source ↗

Summary

Clinical trial update announcing the completion and posted results of the MiniMed 780G glycemic control study in pediatric and adult subjects with Type 1 Diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MiniMed 780G

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes | Status: COMPLETED | Results posted: 2024-07-08